hb-110
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2007 (NCT00513968)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis B virusImmunity, active
Hepatitis B virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hb-110
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01641536 | Phase 1 | Nov 1, 2011 | Catholic University of Korea, Genexine, Inc. |
| NCT00513968 | Phase 1 | Jul 1, 2007 | Catholic University of Korea, Genexine, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Catholic University of Korea | Academic/Hospital | 2 | 0 | 1 | 2007 |
| Genexine, Inc. | For profit | 2 | 2 | 1 | 2007 |
2 organizations
Page 1 / 1